Brian Finan

9.9k total citations · 2 hit papers
57 papers, 3.7k citations indexed

About

Brian Finan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Brian Finan has authored 57 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Brian Finan's work include Diabetes Treatment and Management (31 papers), Pancreatic function and diabetes (21 papers) and Regulation of Appetite and Obesity (14 papers). Brian Finan is often cited by papers focused on Diabetes Treatment and Management (31 papers), Pancreatic function and diabetes (21 papers) and Regulation of Appetite and Obesity (14 papers). Brian Finan collaborates with scholars based in United States, Germany and Denmark. Brian Finan's co-authors include Richard D. DiMarchi, Matthias H. Tschöp, Timo D. Müller, Christoffer Clemmensen, Diego Pérez–Tilve, Jonathan E. Campbell, M. Tschöp, Megan E. Capozzi, Kirk M. Habegger and Paul T. Pfluger and has published in prestigious journals such as Physiological Reviews, PLoS ONE and Endocrine Reviews.

In The Last Decade

Brian Finan

57 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism

2012 565 citations Kirk M. Habegger, Brian Finan et al. profile →
The New Biology and Pharmacology of Glucagon

2017 297 citations Timo D. Müller, Brian Finan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Finan United States	32	1.9k	1.4k	1.1k	1.0k	657	57	3.7k
Anna Secher Denmark	19	849 0.5×	1.2k 0.8×	625 0.6×	493 0.5×	652 1.0×	33	2.6k
Johan Fernø Norway	36	716 0.4×	1.0k 0.7×	1.6k 1.5×	700 0.7×	973 1.5×	80	3.5k
Kirk M. Habegger United States	24	692 0.4×	947 0.7×	907 0.9×	590 0.6×	522 0.8×	59	2.5k
Julio E. Ayala United States	31	894 0.5×	1.6k 1.2×	1.6k 1.5×	972 0.9×	481 0.7×	65	3.7k
Alessandro Pocai United States	33	1.5k 0.8×	2.1k 1.5×	2.2k 2.1×	1.6k 1.5×	2.0k 3.1×	55	5.9k
Anita M. Hennige Germany	36	1.0k 0.5×	1.4k 1.0×	1.3k 1.2×	874 0.9×	625 1.0×	78	3.8k
Hail Kim South Korea	33	795 0.4×	1.5k 1.1×	916 0.9×	1.2k 1.2×	225 0.3×	82	3.8k
Tamer Coşkun United States	32	1.7k 0.9×	2.7k 1.9×	1.6k 1.5×	997 1.0×	922 1.4×	98	5.5k
Diego Pérez–Tilve United States	42	1.8k 1.0×	1.5k 1.0×	2.5k 2.4×	1.4k 1.3×	2.4k 3.7×	99	5.8k
Roger Corder United Kingdom	36	588 0.3×	1.4k 1.0×	1.3k 1.3×	569 0.6×	371 0.6×	127	4.5k

Countries citing papers authored by Brian Finan

Since Specialization

Citations

This map shows the geographic impact of Brian Finan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Finan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Finan more than expected).

Fields of papers citing papers by Brian Finan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Finan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Finan. The network helps show where Brian Finan may publish in the future.

Co-authorship network of co-authors of Brian Finan

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Finan. A scholar is included among the top collaborators of Brian Finan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Finan. Brian Finan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Na, Ahmed Khalil, Arkadiusz Liśkiewicz, et al.. (2025). Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism. Molecular Metabolism. 96. 102136–102136. 1 indexed citations

Zaykov, Alexander N., Vasily M. Gelfanov, Tina M. Tagmose, et al.. (2024). Toward once-monthly insulin therapy via synergy in two pharmacokinetic protractors: Fc-conjugation and fatty acid acylation. RSC Chemical Biology. 5(8). 763–775. 2 indexed citations

El, Kimberley, Jonathan D. Douros, Francis S. Willard, et al.. (2023). The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets. Nature Metabolism. 5(6). 945–954. 74 indexed citations

Campbell, Jonathan E., Timo D. Müller, Brian Finan, et al.. (2023). GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications. Cell Metabolism. 35(9). 1519–1529. 74 indexed citations

Kim, Teayoun, Jodi R. Paul, Cassie Holleman, et al.. (2021). Glucagon-receptor signaling regulates weight loss via central KLB receptor complexes. JCI Insight. 6(4). 25 indexed citations

Novikoff, Aaron, Shannon O’Brien, Gerald Grandl, et al.. (2021). Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists. Molecular Metabolism. 49. 101181–101181. 60 indexed citations

Sachs, Stephan, Lili Niu, Philipp E. Geyer, et al.. (2020). Plasma proteome profiles treatment efficacy of incretin dual agonism in diet‐induced obese female and male mice. Diabetes Obesity and Metabolism. 23(1). 195–207. 16 indexed citations

Zizzari, Philippe, Rongjun He, Sarah Falk, et al.. (2020). CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity. Diabetes. 70(2). 415–422. 27 indexed citations

Capozzi, Megan E., et al.. (2019). Glucagon lowers glycemia when β cells are active. JCI Insight. 4(16). 120 indexed citations

10.

Ratner, Cecilia, Zhenyan He, Kaare V. Grunddal, et al.. (2019). Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway. Diabetes. 68(6). 1329–1340. 35 indexed citations

11.

Knerr, Patrick J., Stephanie A. Mowery, Brian Finan, et al.. (2019). Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates. Peptides. 125. 170225–170225. 40 indexed citations

12.

Décarie-Spain, Léa, Alexandre Fisette, Bin Yang, et al.. (2019). GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice. Neuropharmacology. 151. 55–63. 20 indexed citations

13.

Mróz, Piotr, Brian Finan, Vasily M. Gelfanov, et al.. (2018). Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism. Molecular Metabolism. 20. 51–62. 167 indexed citations

14.

Clemmensen, Christoffer, Brian Finan, Timo D. Müller, et al.. (2018). Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases. Nature Reviews Endocrinology. 15(2). 90–104. 94 indexed citations

15.

Müller, Timo D., Christoffer Clemmensen, Brian Finan, Richard D. DiMarchi, & M. Tschöp. (2018). Anti-Obesity Therapy: from Rainbow Pills to Polyagonists. Pharmacological Reviews. 70(4). 712–746. 140 indexed citations

16.

Guo, ZengKui, Bhavani S. Sahu, Rongjun He, et al.. (2018). Clearance kinetics of the VGF-derived neuropeptide TLQP-21. Neuropeptides. 71. 97–103. 14 indexed citations

17.

Tschöp, Matthias H., Brian Finan, Christoffer Clemmensen, et al.. (2016). Unimolecular Polypharmacy for Treatment of Diabetes and Obesity. Cell Metabolism. 24(1). 51–62. 192 indexed citations

18.

Finan, Brian, Christoffer Clemmensen, & Timo D. Müller. (2015). Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists. Molecular and Cellular Endocrinology. 418. 42–54. 66 indexed citations

19.

Fischer, Katrin, et al.. (2015). The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin Receptor. Frontiers in Nutrition. 1. 31–31. 7 indexed citations

20.

Fuente-Martín, Esther, Cristina García‐Cáceres, Eugenia Morselli, et al.. (2013). Estrogen, astrocytes and the neuroendocrine control of metabolism. Reviews in Endocrine and Metabolic Disorders. 14(4). 331–338. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact